Moderna gains after lifting annual revenue growth view
** Shares of Moderna MRNA.O rise 8.9% to $262.50 in afternoon trading
** Co now expects total revenue growth of 15% to 25% in 2026, above its previous outlook of up to 10% growth
** Q3 rev of $1.3 billion tops analysts' average estimate of $885.1 million, according to data compiled by LSEG
** Quarterly net income was $162 million, compared with a net loss of $200 million YoY
** Including session's moves, stock has risen nearly nine-fold YTD